Hello everyone. Our today’s topic is insulin resistance and this topic is as important as diabetes. Spreading awareness about this topic can be a game changer in managing diabetes. So let’s get started
Insulin resistance is one of the most important metabolic disorders worldwide and is considered the cornerstone of type 2 diabetes mellitus, obesity, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and cardiovascular disease. It often develops years before diabetes becomes clinically apparent, making early recognition and intervention essential.
According to recent guidelines from the American Diabetes Association (ADA), insulin resistance plays a central role in the development of prediabetes and type 2 diabetes and should be addressed through lifestyle modification, weight management, and treatment of associated metabolic risk factors.
What Is Insulin Resistance?
Insulin resistance is a condition in which the body’s cells become less responsive to the action of insulin. As a result, the pancreas must produce increasingly larger amounts of insulin to maintain normal blood glucose levels.
Initially, the pancreas compensates by increasing insulin secretion (hyperinsulinemia). Over time, pancreatic beta cells become unable to meet the increased demand, leading to:
Prediabetes
Type 2 diabetes mellitus
Metabolic syndrome
Cardiovascular disease
In simple terms, insulin is present, but the body’s tissues do not respond to it effectively.
Normal Physiology of Insulin
Insulin is produced by pancreatic beta cells and has several important functions:
In Skeletal Muscle
Promotes glucose uptake
Stimulates glycogen synthesis
Enhances protein synthesis
In Adipose Tissue
Promotes fat storage
Inhibits lipolysis
In the Liver
Suppresses gluconeogenesis
Reduces hepatic glucose output
Promotes glycogen storage
When insulin resistance develops, these effects become impaired, resulting in elevated blood glucose levels and abnormal lipid metabolism.
Pathophysiology of Insulin Resistance
Insulin resistance is a complex disorder involving multiple organs.
- Skeletal Muscle Insulin Resistance
Skeletal muscle is responsible for most insulin-mediated glucose disposal.
In insulin resistance:
GLUT-4 translocation decreases
Glucose uptake falls
Postprandial hyperglycemia develops
- Hepatic Insulin Resistance
The liver continues producing glucose despite elevated insulin levels.
Consequences include:
Increased gluconeogenesis
Elevated fasting glucose
Increased triglyceride production
- Adipose Tissue Dysfunction
Excess visceral fat releases:
Free fatty acids
Tumor necrosis factor-alpha (TNF-α)
Interleukin-6
Other inflammatory mediators
These substances worsen insulin signaling and create chronic low-grade inflammation.
- Chronic Hyperinsulinemia
As insulin resistance progresses:
Pancreatic beta cells secrete more insulin
Blood insulin levels rise
Eventually beta-cell exhaustion occurs
This leads to prediabetes and subsequently type 2 diabetes.
Insulin resistance: Causes and Risk Factors
Obesity
The strongest modifiable risk factor.
Visceral obesity is particularly associated with insulin resistance.
Physical Inactivity
Sedentary individuals have lower insulin sensitivity than physically active individuals.
Genetic Predisposition
Family history significantly increases risk.
Aging
Insulin sensitivity naturally decreases with age.
Pregnancy
Can lead to gestational insulin resistance and gestational diabetes.
Sleep Disorders
Obstructive sleep apnea
Chronic sleep deprivation
Both contribute to insulin resistance.
Endocrine Disorders
Polycystic ovary syndrome (PCOS)
Cushing syndrome
Acromegaly
Hypothyroidism
Medications
Glucocorticoids
Certain antipsychotics
Some antiretroviral drugs
Insulin resistance: clinical manifestations
Many patients remain asymptomatic for years.
Symptoms may include:
Weight gain
Central obesity
Fatigue
Increased hunger
Sugar cravings
Difficulty losing weight
Physical Signs of Insulin Resistance
Acanthosis Nigricans
Velvety hyperpigmented skin commonly found on:
Neck
Axillae
Groin
Highly suggestive of hyperinsulinemia.
Skin Tags
Frequently associated with insulin resistance.
Central Obesity
Waist circumference is often increased.
Features of PCOS
Women may present with:
Irregular menses
Infertility
Hirsutism
Acne
Insulin resistance: complications
Prediabetes
An intermediate state between normal glucose regulation and diabetes.
Diagnostic Criteria
Fasting Plasma Glucose
Normal: <100 mg/dL
Prediabetes: 100–125 mg/dL
Diabetes: ≥126 mg/dL
HbA1c
Normal: <5.7%
Prediabetes: 5.7–6.4%
Diabetes: ≥6.5%
Type 2 Diabetes Mellitus
The most common long-term consequence.
Metabolic Syndrome
Characterized by:
Central obesity
Hypertension
Hyperglycemia
High triglycerides
Low HDL cholesterol
Non-Alcoholic Fatty Liver Disease (NAFLD)
Strongly linked to insulin resistance.
Cardiovascular Disease
Insulin resistance contributes to:
Atherosclerosis
Coronary artery disease
Stroke
Heart failure
Insulin resistance: Diagnosis
There is no universally accepted clinical diagnostic test.
Clinical Assessment
Evaluate:
BMI
Waist circumference
Blood pressure
Family history
Lifestyle factors
Laboratory Tests
Fasting Blood Glucose
Useful for detecting prediabetes and diabetes.
HbA1c
Reflects average glucose over 2–3 months.
Lipid Profile
Common findings:
High triglycerides
Low HDL cholesterol
Fasting Insulin
May be elevated but is not routinely recommended for screening in most clinical settings.
Insulin resistance: Treatment
Lifestyle Modification: First-Line Therapy
Lifestyle intervention remains the most effective treatment for most patients.
Weight Loss
Even a 5–10% reduction in body weight significantly improves insulin sensitivity.
Recent ADA recommendations continue to emphasize weight reduction as a primary therapeutic target.
Nutrition Therapy
Mediterranean Diet
Rich in:
Vegetables
Fruits
Whole grains
Olive oil
Fish
Associated with improved insulin sensitivity.
Low-Carbohydrate Diet
May reduce postprandial glucose excursions and improve metabolic parameters.
ADA recognizes Mediterranean-style and low-carbohydrate dietary patterns as evidence-based approaches for diabetes prevention and metabolic health.
Physical Activity
Aerobic Exercise
At least:
150 minutes/week
Moderate intensity
Examples:
Brisk walking
Cycling
Swimming
Resistance Training
At least 2–3 sessions weekly.
Exercise improves insulin sensitivity independent of weight loss.
Pharmacological Treatment
Metformin
Most commonly used insulin-sensitizing agent.
Benefits:
Reduces hepatic glucose production
Improves insulin sensitivity
Promotes modest weight loss
Particularly useful in:
Prediabetes
Type 2 diabetes
PCOS
GLP-1 Receptor Agonists
Examples:
Semaglutide
Tirzepatide
Liraglutide
Benefits:
Significant weight reduction
Improved insulin sensitivity
Cardiovascular benefits
Recent ADA recommendations place increasing emphasis on obesity pharmacotherapy as part of comprehensive metabolic management
SGLT2 Inhibitors
Provide:
Weight reduction
Cardiovascular protection
Renal protection
Useful in appropriate patients with type 2 diabetes.
Insulin resistance: prevention
Evidence-based preventive measures include:
Maintaining healthy body weight
Regular physical activity
Avoiding excessive sugar consumption
Adequate sleep
Smoking cessation
Limiting ultra-processed foods
Early treatment of obesity
Annual screening is recommended in individuals with overweight, obesity, prediabetes, or other risk factors.
After reading this blog you must have realised why early detection of insulin resistance is important and how you can deal with it. We will also wrote a detailed blog on diabetes or it might be a series of blogs. Till then. Good bye